.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Citi
Healthtrust
Cerilliant
Chinese Patent Office
Federal Trade Commission
Baxter
Cipla
Johnson and Johnson
Daiichi Sankyo

Generated: November 21, 2017

DrugPatentWatch Database Preview

RASUVO Drug Profile

« Back to Dashboard

What is the patent landscape for Rasuvo, and what generic Rasuvo alternatives are available?

Rasuvo is a drug marketed by Medac Pharma Inc and is included in one NDA. There is one patent protecting this drug.

This drug has twenty-seven patent family members in nineteen countries.

The generic ingredient in RASUVO is methotrexate. There are twenty drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methotrexate profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medac Pharma Inc
RASUVO
methotrexate
SOLUTION;SUBCUTANEOUS205776-001Jul 10, 2014RXNoNo► Subscribe► Subscribe ► Subscribe
Medac Pharma Inc
RASUVO
methotrexate
SOLUTION;SUBCUTANEOUS205776-007Jul 10, 2014RXNoNo► Subscribe► Subscribe ► Subscribe
Medac Pharma Inc
RASUVO
methotrexate
SOLUTION;SUBCUTANEOUS205776-004Jul 10, 2014RXNoNo► Subscribe► Subscribe ► Subscribe
Medac Pharma Inc
RASUVO
methotrexate
SOLUTION;SUBCUTANEOUS205776-008Jul 10, 2014RXNoNo► Subscribe► Subscribe ► Subscribe
Medac Pharma Inc
RASUVO
methotrexate
SOLUTION;SUBCUTANEOUS205776-002Jul 10, 2014RXNoNo► Subscribe► Subscribe ► Subscribe
Medac Pharma Inc
RASUVO
methotrexate
SOLUTION;SUBCUTANEOUS205776-003Jul 10, 2014RXNoNo► Subscribe► Subscribe ► Subscribe
Medac Pharma Inc
RASUVO
methotrexate
SOLUTION;SUBCUTANEOUS205776-006Jul 10, 2014RXNoNo► Subscribe► Subscribe ► Subscribe
Medac Pharma Inc
RASUVO
methotrexate
SOLUTION;SUBCUTANEOUS205776-005Jul 10, 2014RXNoNo► Subscribe► Subscribe ► Subscribe
Medac Pharma Inc
RASUVO
methotrexate
SOLUTION;SUBCUTANEOUS205776-010Jul 10, 2014RXNoNo► Subscribe► Subscribe ► Subscribe
Medac Pharma Inc
RASUVO
methotrexate
SOLUTION;SUBCUTANEOUS205776-009Jul 10, 2014DISCNNoNo► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: RASUVO

Country Document Number Estimated Expiration
CroatiaP20110148► Subscribe
Slovenia2046332► Subscribe
Canada2659662► Subscribe
Austria14872► Subscribe
Ukraine95488► Subscribe
Russian Federation2009106053► Subscribe
South Korea20090079876► Subscribe
Russian Federation2403044► Subscribe
Germany502007005972► Subscribe
South Korea101260554► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Fish and Richardson
Johnson and Johnson
McKesson
Chinese Patent Office
Cerilliant
Federal Trade Commission
Novartis
Citi
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot